Proteomic analysis of proteins regulated by TRPS1 transcription factor in DU145 prostate cancer cells

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 5, 2007, Pages 575-582

  Chang, Glenn T G ^a   Gamble, Simon C ^b   Jhamai, Mila ^a   Wait, Robin ^c   Bevan, Charlotte L ^b   Brinkmann, Albert O ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Antioxidant; DU145; Prostate cancer; Proteomic analysis; TRPS1

Indexed keywords

DISULFIDE; GLYCOLYTIC ENZYME; ISOMERASE; LIPOCORTIN 2; NUCLEAR PROTEIN; RECOMBINANT PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TRPS1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOSKELETON; DENSITOMETRY; DOWN REGULATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MASS SPECTROMETRY; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIOXIDANTS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; PROTEOME; TRANSCRIPTION FACTORS;

EID: 34247635694     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.03.011     Document Type: Article

References (53)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., and Thun M.J. Cancer statistics, 2005, CA. Cancer J. Clin. 55 (2005) 10-30
2. Culig Z., Klocker H., Bartsch G., and Hobisch A. Androgen receptors in prostate cancer. Endocr. Relat. Cancer 9 (2002) 155-170
3. Gelmann E.P. Molecular biology of the androgen receptor. J. Clin. Oncol. 20 (2002) 3001-3015
4. Huggins C., and Hodges C.V. Studies on prostate cancer, effects of castration, of estrogens and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res. 1 (1941) 293-297
5. Feldman B.J., and Feldman D. The development of androgen-independent prostate cancer. Nat. Rev., Cancer 1 (2001) 34-45
6. Arnold J.T., and Isaacs J.T. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr. Relat. Cancer 9 (2002) 61-73
7. Martel C.L., Gumerlock P.H., Meyers F.J., and Lara P.N. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat. Rev. 29 (2003) 171-187
8. Nelson P.S., Han D., Rochon Y., Corthals G.L., Lin B., Monson A., Nguyen V., Franza B.R., Plymate S.R., Aebersold R., and Hood L. Comprehensive analyses of prostate gene expression: convergence of expressed sequence tag databases, transcript profiling and proteomics. Electrophoresis 21 (2000) 1823-1831
9. Lexander H., Hellman U., Palmberg C., Auer G., Hellstrom M., Franzen B., Jornvall H., and Egevad L. Evaluation of two sample preparation methods for prostate proteome analysis. Proteomics 6 (2006) 4370-4380
10. Chang G.T., Blok L.J., Steenbeek M., Veldscholte J., van Weerden W.M., van Steenbrugge G.J., and Brinkmann A.O. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res. 57 (1997) 4075-4081
11. Momeni P., Glockner G., Schmidt O., von Holtum D., Albrecht B., Gillessen-Kaesbach G., Hennekam R., Meinecke P., Zabel B., Rosenthal A., Horsthemke B., and Ludecke H.J. Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I. Nat. Genet. 24 (2000) 71-74
12. Ludecke H.J., Schaper J., Meinecke P., Momeni P., Gross S., von Holtum D., Hirche H., Abramowicz M.J., Albrecht B., Apacik C., Christen H.J., Claussen U., Devriendt K., Fastnacht E., Forderer A., Friedrich U., Goodship T.H., Greiwe M., Hamm H., Hennekam R.C., Hinkel G.K., Hoeltzenbein M., Kayserili H., Majewski F., Mathieu M., McLeod R., Midro A.T., Moog U., Nagai T., Niikawa N., Orstavik K.H., Plochl E., Seitz C., Schmidtke J., Tranebjaerg L., Tsukahara M., Wittwer B., Zabel B., Gillessen-Kaesbach G., and Horsthemke B. Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am. J. Hum. Genet. 68 (2001) 81-91
13. Chang G.T., Steenbeek M., Schippers E., Blok L.J., van Weerden W.M., van Alewijk D.C., Eussen B.H., van Steenbrugge G.J., and Brinkmann A.O. Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. J. Natl. Cancer Inst. 92 (2000) 1414-1421
14. Chang G.T., van den Bemd G.J., Jhamai M., and Brinkmann A.O. Structure and function of GC79/TRPS1, a novel androgen-repressible apoptosis gene. Apoptosis 7 (2002) 13-21
15. Malik T.H., Shoichet S.A., Latham P., Kroll T.G., Peters L.L., and Shivdasani R.A. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. Embo J. 20 (2001) 1715-1725
16. van den Bemd G.J., Jhamai M., Brinkmann A.O., and Chang G.T. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells. Biochem. Biophys. Res. Commun. 312 (2003) 578-584
17. Kaiser F.J., Moroy T., Chang G.T., Horsthemke B., and Ludecke H.J. The RING finger protein RNF4, a co-regulator of transcription, interacts with the TRPS1 transcription factor. J. Biol. Chem. 278 (2003) 38780-38785
18. Kaiser F.J., Tavassoli K., Van den Bemd G.J., Chang G.T., Horsthemke B., Moroy T., and Ludecke H.J. Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1. Hum. Mol. Genet. 12 (2003) 1349-1358
19. Moilanen A.M., Poukka H., Karvonen U., Hakli M., Janne O.A., and Palvimo J.J. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol. Cell Biol. 18 (1998) 5128-5139
20. Chang G.T., Jhamai M., van Weerden W.M., Jenster G., and Brinkmann A.O. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer. Endocr. Relat. Cancer 11 (2004) 815-822
21. Corbett J.M., Wheeler C.H., Baker C.S., Yacoub M.H., and Dunn M.J. The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis 15 (1994) 1459-1465
22. Krauss M.R., Collins P.J., and Blose S.H. A two-dimensional acrylamide gel electrophoresis/computer software approach to decoding the human genome. BioTechniques 8 (1990) 218-223
23. Wait R., Gianazza E., Eberini I., Sironi L., Dunn M.J., Gemeiner M., and Miller I. Proteins of rat serum, urine, and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison. Electrophoresis 22 (2001) 3043-3052
24. Wright A., Wait R., Begum S., Crossett B., Nagy J., Brown K., and Fairweather N. Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 5 (2005) 2443-2452
25. Gamble S.C., Odontiadis M., Waxman J., Westbrook J.A., Dunn M.J., Wait R., Lam E.W., and Bevan C.L. Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene 23 (2004) 2996-3004
26. Salvemini D., and Cuzzocrea S. Superoxide, superoxide dismutase and ischemic injury. Curr. Opin. Investig. Drugs 3 (2002) 886-895
27. Jessop C.E., Chakravarthi S., Watkins R.H., and Bulleid N.J. Oxidative protein folding in the mammalian endoplasmic reticulum. Biochem. Soc. Trans. 32 (2004) 655-658
28. Argon Y., and Simen B.B. GRP94, an ER chaperone with protein and peptide binding properties. Semin. Cell Dev. Biol. 10 (1999) 495-505
29. Hayes M.J., and Moss S.E. Annexins and disease. Biochem. Biophys. Res. Commun. 322 (2004) 1166-1170
30. Sullivan D.M., Wehr N.B., Fergusson M.M., Levine R.L., and Finkel T. Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry 39 (2000) 11121-11128
31. Tanaka T., Akatsuka S., Ozeki M., Shirase T., Hiai H., and Toyokuni S. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 23 (2004) 3980-3989
32. He X.Y., Yang Y.Z., Peehl D.M., Lauderdale A., Schulz H., and Yang S.Y. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 87 (2003) 191-198
33. De Pinto V., Messina A., Accardi R., Aiello R., Guarino F., Tomasello M.F., Tommasino M., Tasco G., Casadio R., Benz R., De Giorgi F., Ichas F., Baker M., and Lawen A. New functions of an old protein: the eukaryotic porin or voltage dependent anion selective channel (VDAC). Ital. J. Biochem. 52 (2003) 17-24
34. Madesh M., and Hajnoczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J. Cell Biol. 155 (2001) 1003-1015
35. Cheng E.H., Sheiko T.V., Fisher J.K., Craigen W.J., and Korsmeyer S.J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301 (2003) 513-517
36. Nobumoto M., Yamada M., Song S., Inouye S., and Nakazawa A. Mechanism of mitochondrial import of adenylate kinase isozymes. J. Biochem. (Tokyo) 123 (1998) 128-135
37. Kohler C., Gahm A., Noma T., Nakazawa A., Orrenius S., and Zhivotovsky B. Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis. FEBS Lett. 447 (1999) 10-12
38. Ichihara A., and Greenberg D.M. Studies on the purification and properties of d-glyceric acid kinase of liver. J. Biol. Chem. 225 (1957) 949-958
39. Yamada K., and Noguchi T. Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem. J. 337 Pt 1 (1999) 1-11
40. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1432 (1999) 159-184
41. Wentzel P., Ejdesjo A., and Eriksson U.J. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes 52 (2003) 1222-1228
42. Kubota H. Function and regulation of cytosolic molecular chaperone CCT. Vitam. Horm. 65 (2002) 313-331
43. Belgrader P., Dey R., and Berezney R. Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain. J. Biol. Chem. 266 (1991) 9893-9899
44. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., and Paulson D.F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21 (1978) 274-281
45. Ripple M.O., Henry W.F., Rago R.P., and Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl. Cancer Inst. 89 (1997) 40-48
46. Pang S.T., Dillner K., Wu X., Pousette A., Norstedt G., and Flores-Morales A. Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology 143 (2002) 4897-4906
47. Tam N.N., Gao Y., Leung Y.K., and Ho S.M. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am. J. Pathol. 163 (2003) 2513-2522
48. van der Vlies D., Pap E.H., Post J.A., Celis J.E., and Wirtz K.W. Endoplasmic reticulum resident proteins of normal human dermal fibroblasts are the major targets for oxidative stress induced by hydrogen peroxide. Biochem. J. 366 (2002) 825-830
49. Baek H.Y., Lim J.W., Kim H., Kim J.M., Kim J.S., Jung H.C., and Kim K.H. Oxidative-stress-related proteome changes in Helicobacter pylori-infected human gastric mucosa. Biochem. J. 379 (2004) 291-299
50. Torroja L., Ortuno-Sahagun D., Ferrus A., Hammerle B., and Barbas J.A. Scully, an essential gene of Drosophila, is homologous to mammalian mitochondrial type II L-3-hydroxyacyl-CoA dehydrogenase/amyloid-beta peptide-binding protein. J. Cell Biol. 141 (1998) 1009-1017
51. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R.B., and Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15 (2001) 1406-1418
52. Danial N.N., Gramm C.F., Scorrano L., Zhang C.Y., Krauss S., Ranger A.M., Datta S.R., Greenberg M.E., Licklider L.J., Lowell B.B., Gygi S.P., and Korsmeyer S.J. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424 (2003) 952-956
53. Cuzzocrea S., Riley D.P., Caputi A.P., and Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53 (2001) 135-159